5-Loxin

For knee osteoarthritis, the best-known 5-Loxin trials used 100 mg or 250 mg daily for 90 days, with improvements in pain and physical function.1^,2 The strongest practical starting point is the lower studied dose, then reassess comfort and movement after several weeks rather than chasing a larger dose immediately. Research on stiffness and broader pain uses a similar low-dose extract approach, while claims about protecting cartilage need more confirmation.1^,2

Take it daily and give it time. The key knee trials tested steady daily use across 90 days, not occasional doses taken only on high-pain days.1^,2 Follow the product's directions for splitting or taking the dose with a meal, since the trial evidence supports consistency more clearly than a particular clock time.

Look for a product that explicitly says 5-Loxin and lists AKBA standardization, rather than assuming any bottle labeled boswellia matches the research. The clinical knee trials tested this defined Boswellia serrata extract, so generic resin powder and extracts with undisclosed boswellic-acid content are not interchangeable.1^,2 Aflapin is another standardized boswellia extract studied in knee osteoarthritis, but it is a distinct product from 5-Loxin.3

5-Loxin is a concentrated extract from Boswellia serrata, the tree resin better known as frankincense. It is standardized to contain acetyl-11-keto-beta-boswellic acid, usually shortened to AKBA, rather than relying on the wildly variable mix found in ordinary resin powders.1^,2

AKBA turns down 5-lipoxygenase, an enzyme that helps build leukotrienes, chemical alarm signals that can keep an irritated joint switched on.1 Think of it like lowering the volume on one channel of the joint's alarm system, rather than trying to mute every signal your immune system needs.1^,2 Trials also tracked changes in cartilage-breakdown markers, though the cartilage finding remains early rather than settled.1^,2